Balyasny Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,006
| Closed | -$17.6K | – | 2508 |
|
|
2024
Q3 | $17.6K | Buy |
+10,006
| New | +$17.6K | ﹤0.01% | 1890 |
|
|
2024
Q2 | – | Sell |
-849,447
| Closed | -$7.68M | – | 2547 |
|
|
2024
Q1 | $7.68M | Buy |
+849,447
| New | +$7.68M | 0.01% | 761 |
|
|
2023
Q4 | – | Sell |
-15,873
| Closed | -$128K | – | 2366 |
|
|
2023
Q3 | $128K | Buy |
+15,873
| New | +$128K | ﹤0.01% | 1613 |
|
|
2023
Q2 | – | Sell |
-17,423
| Closed | -$120K | – | 2496 |
|
|
2023
Q1 | $120K | Buy |
+17,423
| New | +$120K | ﹤0.01% | 1860 |
|
|
2018
Q4 | – | Sell |
-52,560
| Closed | -$2.1M | – | 1637 |
|
|
2018
Q3 | $2.1M | Buy |
+52,560
| New | +$2.1M | 0.01% | 762 |
|
|
2018
Q1 | – | Sell |
-250,250
| Closed | -$8.17M | – | 2093 |
|
|
2017
Q4 | $8.17M | Buy |
+250,250
| New | +$8.17M | 0.03% | 591 |
|